Command Palette

Search for a command to run...

Clinical Trials · NCT03036800

Saxenda in Obesity Services (STRIVE Study)

CompletedPhase 4Liraglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
University of Leicester
Enrollment
392
Start date
Nov 2017
Locations
5 sites, Ireland, United Kingdom
Primary endpoint
Weight Loss of ≥15% From Baseline (Complete Cases)
View Liraglutide compound reference